Pages
Public invited to online NHS health meeting
https://dchs.nhs.uk/news/public-invited-online-nhs-health-meeting
Dr Chris Clayton appointed as Chief Executive Designate JUCD
The appointment of Dr Chris Clayton as Chief Executive Designate of the NHS Integrated Care Board for Derby and Derbyshire.
Every Baby Matters resources
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/every-baby-matters-resources
"Think which service" this winter, urge health leaders
https://dchs.nhs.uk/news/think-which-service-winter-urge-health-leaders
Derbyshire NHS helping new parents with baby feeding campaign
https://dchs.nhs.uk/news/derbyshire-nhs-helping-new-parents-baby-feeding-campaign
Metal shell of new NHS facility in Chesterfield takes shape ahead of installation
https://dchs.nhs.uk/news/metal-shell-new-nhs-facility-chesterfield-takes-shape-ahead-installation
Files
DCHS CLINICAL OBERVATIONS version 4.2
Clinical Observations Peoples Development
Organisational, Individual and Committee Responsibilities for IP and C Guidelines (G279)
G279 - Organisational, Individual and Committee Responsibilities for IP&C Guidelines (Section 5.2 in P69)
Operating Standard PPE Jan21
Operating Standard PPE Jan21
Off Loading Heel Cards (Diabetic and Non-Diabetic Patient) (G245)
G245 – Off Loading Heel Cards (Diabetic and Non-Diabetic Patient).
COVID-19 and Respiratory Illnesses Guideline and Procedure (Section 6.17) (G278)
COVID-19 & Respiratory Illnesses Guideline and Procedure
DCHS Organisational Strategy 2023 - 2028
54016 DCHS Organisational Strategy 2023 - 2028 Final Interactive
Clinical Harms Review Additional detail for Service Level SOP - Community Podiatry Service (S113)
This document should be read in conjunction with the overarching DCHS Standard Operating procedure on Clinical Harms which outlines the processes to be followed in order to deliver a consistent approach to: • Utilising a proactive method of risk stratification to minimise clinical harm as a result of delays in care. • Embedding systems which consider health inequalities. • Monitoring waiting times against defined thresholds across pathways of care. • Delivering personalised, patient-centred communications to patients who are waiting for care. • Implementing Harm Reviews for the that support the Trusts governance and assurance processes and maintains practice in line with national expectations.
A1a - Administration guide for SPOA (P91)
A1a - Administration guide for SPOA
DCHS Inpatient Pharmacist Prescribing Framework (G317)
G317 - DCHS Inpatient Pharmacist Prescribing Framework
Patient Initiated Follow Up Leaflet (L325)
Patient Initiated Follow Up Leaflet